US2008107633A1PendingUtilityA1

Cultures of human CNS neural stem cells

Assignee: CARPENTER MELISSAPriority: Sep 5, 1997Filed: Sep 21, 2007Published: May 8, 2008
Est. expirySep 5, 2017(expired)· nominal 20-yr term from priority
C12N 2501/115C12N 2500/90A61K 2035/126C12N 2501/392A61K 35/12C12N 2501/235C12N 2503/02A61P 25/00A61K 35/30C12N 5/0623C12N 2501/105C12N 2500/34C12N 2501/11G01N 33/5005A61K 48/00C12N 2500/25
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides a cell culture including proliferating human neural stem cells with a doubling rate faster than thirty days. The invention also provides a cell culture media for proliferating mammalian neural cells including a standard defined culture medium, a carbohydrate source, a buffer, a source of hormones, one or more growth factors that stimulate the proliferation of neural stem cells, and LIF. The invention also provides a method for protecting, repairing or replacing damaged tissue comprising transplanting mammalian neural stem cells formed into neurospheres. The invention also provides a cell culture of differentiated human neural stem cells where the cells are glioblasts. The invention also provides a method of differentiating human neural stem cells in culture media.

Claims

exact text as granted — not AI-modified
1 . A method for implanting neural stem cells in the central nervous system of a patient comprising transplanting a therapeutically effective amount of human neural stem cell cultures comprising human neural stem cells that have a doubling rate faster than 30 days, wherein the cultures comprise cells which stain positive for nestin, and wherein in the presence of differentiation-inducing conditions said cells produce progeny cells that differentiate into neurons, astrocytes, or oligodendrocytes.  
     
     
         2 . The method of  claim 1 , wherein the human neural stem cells have a doubling rate of 5-10 days.  
     
     
         3 . The method of  claim 1 , wherein the human neural stem cells are substantially formed into neurospheres of a diameter between 10-500 μm.  
     
     
         4 . The method of  claim 1 , wherein the cultures comprise between 10,000 and 1,000,000 cells/μl.  
     
     
         5 . The method of  claim 1 , wherein the cells are proliferated in suspension culture.  
     
     
         6 . The method of  claim 1 , wherein the cells are proliferated in an adherent culture.  
     
     
         7 . The method of  claim 1 , wherein the progeny of said neural stem cells are genetically modified.  
     
     
         8 . A method for implanting neural stem cells in the central nervous system of a patient comprising: 
 a) obtaining a culture comprising human neural stem cells having a doubling rate faster than 30 days, wherein the cultures comprise cells which stain positive for nestin, and wherein in the presence of differentiation-inducing conditions said cells produce progeny cells that differentiate into neurons, astrocytes, or oligodendrocytes;    b) exposing said culture to differentiation inducing-conditions; and    c) transplanting a therapeutically effective amount of said neurons, astrocytes, or oligodendrocytes to the central nervous system of the patient.

Join the waitlist — get patent alerts

Track US2008107633A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.